NIAID Banner Logo Image

Mycobacterium Citations List: July, 2018

Literature Citations

1. Microwave Assisted Synthesis of Some Novel bis-(2-Substituted imidazole[2,1-b][1,3,4]thiadiazole) Derivatives and Their Biological Activities. Baba, N.H.K., D. Ashok, B.A. Rao, M. Sarasija, and N.Y.S. Murthy. Indian Journal of Heterocyclic Chemistry, 2018. 28(1): p. 163-168. ISI[000437472600016].
[WOS]. TB_07_2018.

2. Design, Synthesis, and in Vitro Antitubercular Activity of 1,2,3-Triazolyl-dihydroquinoline Derivatives. Banu, S., R. Bollu, L. Nagarapu, J.B. Nanubolu, P. Yogeswari, D. Sriram, S.K. Gunda, and D. Vardhan. Chemical Biology & Drug Design, 2018. 92(1): p. 1315-1323. PMID[29624868].
[PubMed]. TB_07_2018.

3. Bioactive Pyridone Alkaloids from a Deep-sea-derived Fungus Arthrinium sp UJNMF0008. Bao, J., H.J. Zhai, K.K. Zhu, J.H. Yu, Y.Y. Zhang, Y.Y. Wang, C.S. Jiang, X.Y. Zhang, Y. Zhang, and H. Zhang. Marine Drugs, 2018. 16(5). E174. PMID[29786655]. PMCID[PMC5983305].
[PubMed]. TB_07_2018.

4. Anti-Mycobacterium tuberculosis Activity of Naphthoimidazoles Combined with Isoniazid and Rifampicin. Correa Barros, L.P., K.P. Del Rio, T. Carvalho, M. Pinto, K.C.G. de Moura, P.C.B. Halicki, D.F. Ramos, and P.E.A. da Silva. Tuberculosis, 2018. 111: p. 198-201. PMID[30029908].
[PubMed]. TB_07_2018.

5. Effect of Linezolid Plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-persister Phase in an in Vitro Assay. de Miranda Silva, C., A. Hajihosseini, J. Myrick, J. Nole, A. Louie, S. Schmidt, and G.L. Drusano. Antimicrobial Agents and Chemotherapy, 2018. 62(8). e00856-18. PMID[29866874].
[PubMed]. TB_07_2018.

6. Design, Synthesis, Biological Evaluation and Molecular Modeling Study of Novel Indolizine-1-carbonitrile Derivatives as Potential Anti-microbial Agents. Faghih-Mirzaei, E., M. Seifi, M. Abaszadeh, K. Zomorodian, and H. Helali. Iranian Journal of Pharmaceutical Research, 2018. 17(3): p. 883-895. ISI[000438319600007].
[WOS]. TB_07_2018.

7. In Vitro Combinatory Activity of Piperine and Anti-tuberculosis Drugs in Mycobacterium tuberculosis. Hegeto, L.A., K.R. Caleffi-Ferracioli, S.S. Nakamura-Vasconcelos, A.L. Almeida, V.P. Baldin, C.V. Nakamura, V.L.D. Siqueira, R.B.L. Scodro, and R.F. Cardoso. Tuberculosis, 2018. 111: p. 35-40. PMID[30029912].
[PubMed]. TB_07_2018.

8. Antimycobacterial and Hypolipemiant Activities of Bidens odorata (Cavanilles). Hernandez-Sanchez, K.M., L. Garduno-Siciliano, J. Luna-Herrera, L.G. Zepeda-Vallejo, S. Lagunas-Rivera, G.E. Garcia-Gutierrez, and M.E. Vargas-Diaz. Journal of Ethnopharmacology, 2018. 222: p. 159-164. PMID[29704591].
[PubMed]. TB_07_2018.

9. Anti-tuberculous, Phytotoxic and Insecticidal Activities of Secondary Metabolites Obtained from Aspergillus and Penicillium Species Isolated from Soil. Idrees, M., B. Ahmad, K. Ahmad, S. Bashir, A. Ali, and K. Aman. Journal of the Pakistan Medical Association, 2018. 68(7): p. 1024-1028. ISI[000437931800010].
[WOS]. TB_07_2018.

10. Antitubercular Activity and Synergistic Study of Novel Pyrazole Derivatives. Jadhav, S.B., S. Fatema, G. Sanap, and M. Farooqui. Journal of Heterocyclic Chemistry, 2018. 55(7): p. 1634-1644. ISI[000438346800011].
[WOS]. TB_07_2018.

11. Synthesis and Antitubercular Activity of Some N'-Substituted benzoyl-4-(2,5dimethyl-1H-pyrrolyl) benzohydrazide Derivatives. Joshi, S.D., S. Vinayak, S.R.P. Kumar, and S.R. Dixit. Indian Journal of Heterocyclic Chemistry, 2018. 28(2): p. 195-200. ISI[000437474300003].
[WOS]. TB_07_2018.

12. Identification of Novel Mycobacteria Inhibitors against Mycobacterial Protein Kinase G. Kanehiro, Y., H. Tomioka, J. Pieters, Y. Tatano , H. Kim, H. Iizasa, and H. Yoshiyama. Frontiers in Microbiology, 2018. 9(1517): 8 pp. PMID[30050511]. PMCID[PMC6052090].
[PubMed]. TB_07_2018.

13. Synthesis, Antimycobacterial Activity and Influence on Mycobacterial InhA and PknB of 12-Membered Cyclodepsipeptides. Laqua, K., M. Klemm, M. Richard-Greenblatt, A. Richter, L. Liebe, T.T. Huang, S.J. Lin, A. Guardia, E. Perez-Herran, L. Ballell, Y. Av-Gay, and P. Imming. Bioorganic & Medicinal Chemistry, 2018. 26(12): p. 3166-3190. PMID[29706526].
[PubMed]. TB_07_2018.

14. In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. Le Run, E., M. Arthur, and J.L. Mainardi. Antimicrobial Agents and Chemotherapy, 2018. 62(8). e00623-18. PMID[29866869].
[PubMed]. TB_07_2018.

15. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus. Li, B., M. Ye, Q. Guo, Z. Zhang, S. Yang, W. Ma, F. Yu, and H. Chu. Antimicrobial Agents and Chemotherapy, 2018. 62(7). e00175-18. PMID[29712658]. PMCID[PMC6021634].
[PubMed]. TB_07_2018.

16. Unprecedented in Vitro Antitubercular Activity of Manganese(II) Complexes Containing 1,10-Phenanthroline and Dicarboxylate Ligands: Increased Activity, Superior Selectivity, and Lower Toxicity in Comparison to Their Copper(II) Analogs. McCarron, P., M. McCann, M. Devereux, K. Kavanagh, C. Skerry, P.C. Karakousis, A.C. Aor, T.P. Mello, A.L.S. Santos, D.L. Campos, and F.R. Pavan. Frontiers in Microbiology, 2018. 9(1432). 10 pp. PMID[30013535]. PMCID[PMC6036174].
[PubMed]. TB_07_2018.

17. Antimicrobial Activity of Essential Oils from Lippia alba, Lippia sidoides, Cymbopogon citrates, Plectranthus amboinicus, and Cinnamomum zeylanicum against Mycobacterium tuberculosis. Mota, A.P.P., J.C.P. Dantas, and C.C. Frota. Ciencia Rural, 2018. 48(6). e20170697. ISI[000436617600001].
[WOS]. TB_07_2018.

18. Synthesis, Characterization, and Antimicrobial Screening of 4-Methyl-2,2''-diaryl-4,2':4,5''-terthiazole Derivatives. Nalawade, J., P.C. Mhaske, A. Shinde, S.V. Patil, P.B. Choudhari, and V.D. Bobade. Journal of Heterocyclic Chemistry, 2018. 55(6): p. 1366-1374. ISI[000435277300013].
[WOS]. TB_07_2018.

19. Synthesis, Characterization, and Antimycobacterial Activity of Novel Thymol-triazole Hybrids. Negi, B. and D.S. Rawat. Indian Journal of Heterocyclic Chemistry, 2018. 28(1): p. 113-123. ISI[000437472600011].
[WOS]. TB_07_2018.

20. Potent 1,2,4-Triazino[5,6b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis. Ngo, H.X., K.D. Green, C.S. Gajadeera, M.J. Willby, S.Y.L. Holbrook, C.X. Hou, A. Garzan, A.S. Mayhoub, J.E. Posey, O.V. Tsodikov, and S. Garneau-Tsodikova. ACS Infectious Diseases, 2018. 4(6): p. 1030-1040. PMID[29601176].
[PubMed]. TB_07_2018.

21. Antitubercular Evaluation of Root Extract and Isolated Phytochemicals from Lophira lanceolata against Two Resistant Strains of Mycobacterium tuberculosis. Nkot, J.L., D.S. Ngono Bikobo, A. Abouem A Zintchem, N.M. Nyemeck 2nd, E.D.F. Moni Ndedi, P.H. Betote Dioue, D.E. Pegnyemb, C.G. Bochet, and U. Koert. Pharmaceutical Biology, 2018. 56(1): p. 318-324. PMID[29969355].
[PubMed]. TB_07_2018.

22. Chemical Composition, Antimicrobial and Antimycobacterial Activities of Aristolochia triangularis Cham. From Brazil. Pereira, A.O., J.M. Avila, G. do Carmo, F.S Siqueira, M.M.A Campos, D.F Back, A.F. Morel, and I.I. Dalcol. Industrial Crops and Products, 2018. 121: p. 461-467. ISI[000437996900053].
[WOS]. TB_07_2018.

23. Combinatory Activity of Linezolid and Levofloxacin with Antituberculosis Drugs in Mycobacterium tuberculosis. Santos, N.C.S., R.B.L. Scodro, A.L. de Almeida, V.P. Baldin, S.S. Nakamura de Vasconcelos, V.L.D. Siqueira, K.R. Caleffi-Ferracioli, P.A.Z. Campanerut-Sa, and R.F. Cardoso. Tuberculosis, 2018. 111: p. 41-44. PMID[30029913].
[PubMed]. TB_07_2018.

24. Pyrimidine-Pyrazole Hybrids as Morpholinopyrimidine-based Pyrazole Carboxamides: Synthesis, Characterisation, Docking, ADMET Study and Biological Evaluation. Vekariya, M.K., R.H. Vekariya, K.D. Patel, N.P. Raval, P.U. Shah, D.P. Rajani, and N.K. Shah. ChemistrySelect, 2018. 3(24): p. 6998-7008. ISI[000436798700042].
[WOS]. TB_07_2018.

25. Design, Synthesis and in Vitro Anti-mycobacterial Activities of Homonuclear and Heteronuclear bis-Isatin Derivatives. Xu, Y., J.G. Guan, Z. Xu, and S.J. Zhao. Fitoterapia, 2018. 127: p. 383-386. PMID[29631015].
[PubMed]. TB_07_2018.

26. Hc2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic acid Transporter. Zheng, H., J.T. Williams, G.B. Coulson, E.R. Haiderer, and R.B. Abramovitch. Antimicrobial Agents and Chemotherapy, 2018. 62(7). e02459-17. PMID[29661875]. PMCID[PMC6021632].
[PubMed]. TB_07_2018.

27. Design, Synthesis and Antimycobacterial Activity of Hybrid Molecules Combining Pyrazinamide with a 4-Phenylthiazol-2-amine Scaffold. Zitko, J., O. Jand'ourek, P. Paterova, L. Navratilova, J. Kunes, J. Vinsova, and M. Dolezal. MedChemComm, 2018. 9(4): p. 685-696. ISI[000435859400009].
[WOS]. TB_07_2018.

28. Comparison of in Vitro Activity and Mic Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-resistant and Extensively Drug-resistant Mycobacterium tuberculosis in China. Zong, Z., W. Jing, J. Shi, S. Wen, T. Zhang, F. Huo, Y. Shang, Q. Liang, H. Huang, and Y. Pang. Antimicrobial Agents and Chemotherapy, 2018. 62(8). e00165-18. PMID[29844043].
[PubMed]. TB_07_2018.

Patent Citations

29. Lipolanthipeptides and Their Uses as Antimicrobial Agents. Le Beller, D. Patent. 2018. 2018-EP50073 2018127493: 81pp.
[Patent]. TB_07_2018.

Database last updated: September 2018